aluates Reports

$ 0.0

Automative

Global Menopausal Medications Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-17H15970

Global Menopausal Medications Market Research Report 2023

BUY CHAPTERS

Global Menopausal Medications Market Research Report 2025

Code: QYRE-Auto-17H15970

Report

May 2025

Pages:99

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Merck

Novartis

Novo Nordisk

Pfizer Inc

Allergan plc

Emcure Pharmaceuticals

Eli Lilly and Company

Bayer

Theramex

AbbVie

Hisamitsu Pharmaceutical

Roche

Tong Ren Tang

Assertio(Depomed)

Xintian Pharmaceutical

Jiangxi Yaodu Zhangshu Pharmaceutical

Jinbao Pharmaceutical

Huaxi Pharmaceutical

Menopausal Medications Market Size

The global market for Menopausal Medications was valued at US$ 17200 million in the year 2024 and is projected to reach a revised size of US$ 23470 million by 2031, growing at a CAGR of 4.6% during the forecast period.

Menopausal Medications Market

The driving force for the development of menopausal drugs mainly comes from the following aspects:

Growing demand for women’s health: As women’s demand for their own health grows, especially as their awareness and emphasis on menopausal syndrome increases, their demand for menopausal drugs is also increasing. These drugs can help relieve menopausal symptoms, such as hot flashes, insomnia, mood swings, etc., and improve quality of life.

Advances in medical technology: In recent years, the continuous advancement of medical technology has provided more means and options for menopausal drug treatment. For example, hormone replacement therapy (HRT) can effectively relieve menopausal symptoms and can also prevent some menopausal-related diseases, such as osteoporosis and cardiovascular disease. In addition, the development of new drugs such as phytoestrogens and natural progestins also provides more options for menopausal drug treatment.

Increased health awareness of consumers: As consumers’ health awareness continues to increase, they have put forward higher requirements for the safety, effectiveness and quality of drugs. Against this background, some new menopausal drugs, such as phytoestrogens and natural progestins, are favored by more and more consumers due to their smaller side effects, more natural and safer characteristics.

Adapt to changes in market demand: As the market changes, pharmaceutical companies are constantly launching new varieties that adapt to market demand. For example, some new menopausal drugs can not only relieve menopausal symptoms, but also have multiple functions such as preventing diseases and improving quality of life, adapting to the diverse needs of modern people for health.

Policy support: The government is also promoting the innovative development of the pharmaceutical industry, and some policies also provide support for the development of menopausal drugs. For example, the state encourages and supports pharmaceutical companies to carry out technological innovation and industrial upgrading, providing a good policy environment for the research, development and application of new drugs.

To sum up, the development drivers of menopausal drugs are multifaceted, including the growth of women’s health needs, advancements in medical technology, increased consumer health awareness, adaptation to changes in market demand, and policy support. These factors jointly promote the continuous innovation and development of menopausal drugs.

This report aims to provide a comprehensive presentation of the global market for Menopausal Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Menopausal Medications.

The Menopausal Medications market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Menopausal Medications market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Menopausal Medications companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Menopausal Medications Market Report

Report Metric	Details
Report Name	Menopausal Medications Market
Accounted market size in year	US$ 17200 million
Forecasted market size in 2031	US$ 23470 million
CAGR	4.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Hormone Drugs Chinese Proprietary Medicine
Segment by Application	Online Sales Offline Sales
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Merck, Novartis, Novo Nordisk, Pfizer, Allergan, Emcure Pharmaceuticals, Eli Lilly And Company, Bayer, Theramex, AbbVie, Assertio(Depomed), Hisamitsu Pharmaceutical, Roche, Xintian Pharmaceutical, Jiangxi Yaodu Zhangshu Pharmaceutical, Jinbao Pharmaceutical, Tong Ren Tang, Huaxi Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Menopausal Medications company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Menopausal Medications Market growing?

Ans: The Menopausal Medications Market witnessing a CAGR of 4.6% during the forecast period 2025-2031.

What is the Menopausal Medications Market size in 2031?

Ans: The Menopausal Medications Market size in 2031 will be US$ 23470 million.

Who are the main players in the Menopausal Medications Market report?

Ans: The main players in the Menopausal Medications Market are Merck, Novartis, Novo Nordisk, Pfizer, Allergan, Emcure Pharmaceuticals, Eli Lilly And Company, Bayer, Theramex, AbbVie, Assertio(Depomed), Hisamitsu Pharmaceutical, Roche, Xintian Pharmaceutical, Jiangxi Yaodu Zhangshu Pharmaceutical, Jinbao Pharmaceutical, Tong Ren Tang, Huaxi Pharmaceutical

What are the Application segmentation covered in the Menopausal Medications Market report?

Ans: The Applications covered in the Menopausal Medications Market report are Online Sales, Offline Sales

What are the Type segmentation covered in the Menopausal Medications Market report?

Ans: The Types covered in the Menopausal Medications Market report are Hormone Drugs, Chinese Proprietary Medicine

Recommended Reports

Menopausal & Hormone

Gynecological Medications

Women's Health Products

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Menopausal Medications Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Hormone Drugs

1.2.3 Chinese Proprietary Medicine

1.3 Market by Application

1.3.1 Global Menopausal Medications Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Online Sales

1.3.3 Offline Sales

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Menopausal Medications Market Perspective (2020-2031)

2.2 Global Menopausal Medications Growth Trends by Region

2.2.1 Global Menopausal Medications Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Menopausal Medications Historic Market Size by Region (2020-2025)

2.2.3 Menopausal Medications Forecasted Market Size by Region (2026-2031)

2.3 Menopausal Medications Market Dynamics

2.3.1 Menopausal Medications Industry Trends

2.3.2 Menopausal Medications Market Drivers

2.3.3 Menopausal Medications Market Challenges

2.3.4 Menopausal Medications Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Menopausal Medications Players by Revenue

3.1.1 Global Top Menopausal Medications Players by Revenue (2020-2025)

3.1.2 Global Menopausal Medications Revenue Market Share by Players (2020-2025)

3.2 Global Menopausal Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Menopausal Medications Revenue

3.4 Global Menopausal Medications Market Concentration Ratio

3.4.1 Global Menopausal Medications Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Menopausal Medications Revenue in 2024

3.5 Global Key Players of Menopausal Medications Head office and Area Served

3.6 Global Key Players of Menopausal Medications, Product and Application

3.7 Global Key Players of Menopausal Medications, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Menopausal Medications Breakdown Data by Type

4.1 Global Menopausal Medications Historic Market Size by Type (2020-2025)

4.2 Global Menopausal Medications Forecasted Market Size by Type (2026-2031)

5 Menopausal Medications Breakdown Data by Application

5.1 Global Menopausal Medications Historic Market Size by Application (2020-2025)

5.2 Global Menopausal Medications Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Menopausal Medications Market Size (2020-2031)

6.2 North America Menopausal Medications Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Menopausal Medications Market Size by Country (2020-2025)

6.4 North America Menopausal Medications Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Menopausal Medications Market Size (2020-2031)

7.2 Europe Menopausal Medications Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Menopausal Medications Market Size by Country (2020-2025)

7.4 Europe Menopausal Medications Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Menopausal Medications Market Size (2020-2031)

8.2 Asia-Pacific Menopausal Medications Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Menopausal Medications Market Size by Region (2020-2025)

8.4 Asia-Pacific Menopausal Medications Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Menopausal Medications Market Size (2020-2031)

9.2 Latin America Menopausal Medications Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Menopausal Medications Market Size by Country (2020-2025)

9.4 Latin America Menopausal Medications Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Menopausal Medications Market Size (2020-2031)

10.2 Middle East & Africa Menopausal Medications Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Menopausal Medications Market Size by Country (2020-2025)

10.4 Middle East & Africa Menopausal Medications Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Merck

11.1.1 Merck Company Details

11.1.2 Merck Business Overview

11.1.3 Merck Menopausal Medications Introduction

11.1.4 Merck Revenue in Menopausal Medications Business (2020-2025)

11.1.5 Merck Recent Development

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Menopausal Medications Introduction

11.2.4 Novartis Revenue in Menopausal Medications Business (2020-2025)

11.2.5 Novartis Recent Development

11.3 Novo Nordisk

11.3.1 Novo Nordisk Company Details

11.3.2 Novo Nordisk Business Overview

11.3.3 Novo Nordisk Menopausal Medications Introduction

11.3.4 Novo Nordisk Revenue in Menopausal Medications Business (2020-2025)

11.3.5 Novo Nordisk Recent Development

11.4 Pfizer

11.4.1 Pfizer Company Details

11.4.2 Pfizer Business Overview

11.4.3 Pfizer Menopausal Medications Introduction

11.4.4 Pfizer Revenue in Menopausal Medications Business (2020-2025)

11.4.5 Pfizer Recent Development

11.5 Allergan

11.5.1 Allergan Company Details

11.5.2 Allergan Business Overview

11.5.3 Allergan Menopausal Medications Introduction

11.5.4 Allergan Revenue in Menopausal Medications Business (2020-2025)

11.5.5 Allergan Recent Development

11.6 Emcure Pharmaceuticals

11.6.1 Emcure Pharmaceuticals Company Details

11.6.2 Emcure Pharmaceuticals Business Overview

11.6.3 Emcure Pharmaceuticals Menopausal Medications Introduction

11.6.4 Emcure Pharmaceuticals Revenue in Menopausal Medications Business (2020-2025)

11.6.5 Emcure Pharmaceuticals Recent Development

11.7 Eli Lilly And Company

11.7.1 Eli Lilly And Company Company Details

11.7.2 Eli Lilly And Company Business Overview

11.7.3 Eli Lilly And Company Menopausal Medications Introduction

11.7.4 Eli Lilly And Company Revenue in Menopausal Medications Business (2020-2025)

11.7.5 Eli Lilly And Company Recent Development

11.8 Bayer

11.8.1 Bayer Company Details

11.8.2 Bayer Business Overview

11.8.3 Bayer Menopausal Medications Introduction

11.8.4 Bayer Revenue in Menopausal Medications Business (2020-2025)

11.8.5 Bayer Recent Development

11.9 Theramex

11.9.1 Theramex Company Details

11.9.2 Theramex Business Overview

11.9.3 Theramex Menopausal Medications Introduction

11.9.4 Theramex Revenue in Menopausal Medications Business (2020-2025)

11.9.5 Theramex Recent Development

11.10 AbbVie

11.10.1 AbbVie Company Details

11.10.2 AbbVie Business Overview

11.10.3 AbbVie Menopausal Medications Introduction

11.10.4 AbbVie Revenue in Menopausal Medications Business (2020-2025)

11.10.5 AbbVie Recent Development

11.11 Assertio(Depomed)

11.11.1 Assertio(Depomed) Company Details

11.11.2 Assertio(Depomed) Business Overview

11.11.3 Assertio(Depomed) Menopausal Medications Introduction

11.11.4 Assertio(Depomed) Revenue in Menopausal Medications Business (2020-2025)

11.11.5 Assertio(Depomed) Recent Development

11.12 Hisamitsu Pharmaceutical

11.12.1 Hisamitsu Pharmaceutical Company Details

11.12.2 Hisamitsu Pharmaceutical Business Overview

11.12.3 Hisamitsu Pharmaceutical Menopausal Medications Introduction

11.12.4 Hisamitsu Pharmaceutical Revenue in Menopausal Medications Business (2020-2025)

11.12.5 Hisamitsu Pharmaceutical Recent Development

11.13 Roche

11.13.1 Roche Company Details

11.13.2 Roche Business Overview

11.13.3 Roche Menopausal Medications Introduction

11.13.4 Roche Revenue in Menopausal Medications Business (2020-2025)

11.13.5 Roche Recent Development

11.14 Xintian Pharmaceutical

11.14.1 Xintian Pharmaceutical Company Details

11.14.2 Xintian Pharmaceutical Business Overview

11.14.3 Xintian Pharmaceutical Menopausal Medications Introduction

11.14.4 Xintian Pharmaceutical Revenue in Menopausal Medications Business (2020-2025)

11.14.5 Xintian Pharmaceutical Recent Development

11.15 Jiangxi Yaodu Zhangshu Pharmaceutical

11.15.1 Jiangxi Yaodu Zhangshu Pharmaceutical Company Details

11.15.2 Jiangxi Yaodu Zhangshu Pharmaceutical Business Overview

11.15.3 Jiangxi Yaodu Zhangshu Pharmaceutical Menopausal Medications Introduction

11.15.4 Jiangxi Yaodu Zhangshu Pharmaceutical Revenue in Menopausal Medications Business (2020-2025)

11.15.5 Jiangxi Yaodu Zhangshu Pharmaceutical Recent Development

11.16 Jinbao Pharmaceutical

11.16.1 Jinbao Pharmaceutical Company Details

11.16.2 Jinbao Pharmaceutical Business Overview

11.16.3 Jinbao Pharmaceutical Menopausal Medications Introduction

11.16.4 Jinbao Pharmaceutical Revenue in Menopausal Medications Business (2020-2025)

11.16.5 Jinbao Pharmaceutical Recent Development

11.17 Tong Ren Tang

11.17.1 Tong Ren Tang Company Details

11.17.2 Tong Ren Tang Business Overview

11.17.3 Tong Ren Tang Menopausal Medications Introduction

11.17.4 Tong Ren Tang Revenue in Menopausal Medications Business (2020-2025)

11.17.5 Tong Ren Tang Recent Development

11.18 Huaxi Pharmaceutical

11.18.1 Huaxi Pharmaceutical Company Details

11.18.2 Huaxi Pharmaceutical Business Overview

11.18.3 Huaxi Pharmaceutical Menopausal Medications Introduction

11.18.4 Huaxi Pharmaceutical Revenue in Menopausal Medications Business (2020-2025)

11.18.5 Huaxi Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Merck

Novartis

Novo Nordisk

Pfizer Inc

Allergan plc

Emcure Pharmaceuticals

Eli Lilly and Company

Bayer

Theramex

AbbVie

Hisamitsu Pharmaceutical

Roche

Tong Ren Tang

Assertio(Depomed)

Xintian Pharmaceutical

Jiangxi Yaodu Zhangshu Pharmaceutical

Jinbao Pharmaceutical

Huaxi Pharmaceutical

List of Tables

Table 1. Global Menopausal Medications Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Hormone Drugs

Table 3. Key Players of Chinese Proprietary Medicine

Table 4. Global Menopausal Medications Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Menopausal Medications Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Menopausal Medications Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Menopausal Medications Market Share by Region (2020-2025)

Table 8. Global Menopausal Medications Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Menopausal Medications Market Share by Region (2026-2031)

Table 10. Menopausal Medications Market Trends

Table 11. Menopausal Medications Market Drivers

Table 12. Menopausal Medications Market Challenges

Table 13. Menopausal Medications Market Restraints

Table 14. Global Menopausal Medications Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Menopausal Medications Market Share by Players (2020-2025)

Table 16. Global Top Menopausal Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Menopausal Medications as of 2024)

Table 17. Ranking of Global Top Menopausal Medications Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Menopausal Medications Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Menopausal Medications, Headquarters and Area Served

Table 20. Global Key Players of Menopausal Medications, Product and Application

Table 21. Global Key Players of Menopausal Medications, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Menopausal Medications Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Menopausal Medications Revenue Market Share by Type (2020-2025)

Table 25. Global Menopausal Medications Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Menopausal Medications Revenue Market Share by Type (2026-2031)

Table 27. Global Menopausal Medications Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Menopausal Medications Revenue Market Share by Application (2020-2025)

Table 29. Global Menopausal Medications Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Menopausal Medications Revenue Market Share by Application (2026-2031)

Table 31. North America Menopausal Medications Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Menopausal Medications Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Menopausal Medications Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Menopausal Medications Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Menopausal Medications Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Menopausal Medications Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Menopausal Medications Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Menopausal Medications Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Menopausal Medications Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Menopausal Medications Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Menopausal Medications Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Menopausal Medications Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Menopausal Medications Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Menopausal Medications Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Menopausal Medications Market Size by Country (2026-2031) & (US$ Million)

Table 46. Merck Company Details

Table 47. Merck Business Overview

Table 48. Merck Menopausal Medications Product

Table 49. Merck Revenue in Menopausal Medications Business (2020-2025) & (US$ Million)

Table 50. Merck Recent Development

Table 51. Novartis Company Details

Table 52. Novartis Business Overview

Table 53. Novartis Menopausal Medications Product

Table 54. Novartis Revenue in Menopausal Medications Business (2020-2025) & (US$ Million)

Table 55. Novartis Recent Development

Table 56. Novo Nordisk Company Details

Table 57. Novo Nordisk Business Overview

Table 58. Novo Nordisk Menopausal Medications Product

Table 59. Novo Nordisk Revenue in Menopausal Medications Business (2020-2025) & (US$ Million)

Table 60. Novo Nordisk Recent Development

Table 61. Pfizer Company Details

Table 62. Pfizer Business Overview

Table 63. Pfizer Menopausal Medications Product

Table 64. Pfizer Revenue in Menopausal Medications Business (2020-2025) & (US$ Million)

Table 65. Pfizer Recent Development

Table 66. Allergan Company Details

Table 67. Allergan Business Overview

Table 68. Allergan Menopausal Medications Product

Table 69. Allergan Revenue in Menopausal Medications Business (2020-2025) & (US$ Million)

Table 70. Allergan Recent Development

Table 71. Emcure Pharmaceuticals Company Details

Table 72. Emcure Pharmaceuticals Business Overview

Table 73. Emcure Pharmaceuticals Menopausal Medications Product

Table 74. Emcure Pharmaceuticals Revenue in Menopausal Medications Business (2020-2025) & (US$ Million)

Table 75. Emcure Pharmaceuticals Recent Development

Table 76. Eli Lilly And Company Company Details

Table 77. Eli Lilly And Company Business Overview

Table 78. Eli Lilly And Company Menopausal Medications Product

Table 79. Eli Lilly And Company Revenue in Menopausal Medications Business (2020-2025) & (US$ Million)

Table 80. Eli Lilly And Company Recent Development

Table 81. Bayer Company Details

Table 82. Bayer Business Overview

Table 83. Bayer Menopausal Medications Product

Table 84. Bayer Revenue in Menopausal Medications Business (2020-2025) & (US$ Million)

Table 85. Bayer Recent Development

Table 86. Theramex Company Details

Table 87. Theramex Business Overview

Table 88. Theramex Menopausal Medications Product

Table 89. Theramex Revenue in Menopausal Medications Business (2020-2025) & (US$ Million)

Table 90. Theramex Recent Development

Table 91. AbbVie Company Details

Table 92. AbbVie Business Overview

Table 93. AbbVie Menopausal Medications Product

Table 94. AbbVie Revenue in Menopausal Medications Business (2020-2025) & (US$ Million)

Table 95. AbbVie Recent Development

Table 96. Assertio(Depomed) Company Details

Table 97. Assertio(Depomed) Business Overview

Table 98. Assertio(Depomed) Menopausal Medications Product

Table 99. Assertio(Depomed) Revenue in Menopausal Medications Business (2020-2025) & (US$ Million)

Table 100. Assertio(Depomed) Recent Development

Table 101. Hisamitsu Pharmaceutical Company Details

Table 102. Hisamitsu Pharmaceutical Business Overview

Table 103. Hisamitsu Pharmaceutical Menopausal Medications Product

Table 104. Hisamitsu Pharmaceutical Revenue in Menopausal Medications Business (2020-2025) & (US$ Million)

Table 105. Hisamitsu Pharmaceutical Recent Development

Table 106. Roche Company Details

Table 107. Roche Business Overview

Table 108. Roche Menopausal Medications Product

Table 109. Roche Revenue in Menopausal Medications Business (2020-2025) & (US$ Million)

Table 110. Roche Recent Development

Table 111. Xintian Pharmaceutical Company Details

Table 112. Xintian Pharmaceutical Business Overview

Table 113. Xintian Pharmaceutical Menopausal Medications Product

Table 114. Xintian Pharmaceutical Revenue in Menopausal Medications Business (2020-2025) & (US$ Million)

Table 115. Xintian Pharmaceutical Recent Development

Table 116. Jiangxi Yaodu Zhangshu Pharmaceutical Company Details

Table 117. Jiangxi Yaodu Zhangshu Pharmaceutical Business Overview

Table 118. Jiangxi Yaodu Zhangshu Pharmaceutical Menopausal Medications Product

Table 119. Jiangxi Yaodu Zhangshu Pharmaceutical Revenue in Menopausal Medications Business (2020-2025) & (US$ Million)

Table 120. Jiangxi Yaodu Zhangshu Pharmaceutical Recent Development

Table 121. Jinbao Pharmaceutical Company Details

Table 122. Jinbao Pharmaceutical Business Overview

Table 123. Jinbao Pharmaceutical Menopausal Medications Product

Table 124. Jinbao Pharmaceutical Revenue in Menopausal Medications Business (2020-2025) & (US$ Million)

Table 125. Jinbao Pharmaceutical Recent Development

Table 126. Tong Ren Tang Company Details

Table 127. Tong Ren Tang Business Overview

Table 128. Tong Ren Tang Menopausal Medications Product

Table 129. Tong Ren Tang Revenue in Menopausal Medications Business (2020-2025) & (US$ Million)

Table 130. Tong Ren Tang Recent Development

Table 131. Huaxi Pharmaceutical Company Details

Table 132. Huaxi Pharmaceutical Business Overview

Table 133. Huaxi Pharmaceutical Menopausal Medications Product

Table 134. Huaxi Pharmaceutical Revenue in Menopausal Medications Business (2020-2025) & (US$ Million)

Table 135. Huaxi Pharmaceutical Recent Development

Table 136. Research Programs/Design for This Report

Table 137. Key Data Information from Secondary Sources

Table 138. Key Data Information from Primary Sources

Table 139. Authors List of This Report

List of Figures

Figure 1. Menopausal Medications Picture

Figure 2. Global Menopausal Medications Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Menopausal Medications Market Share by Type: 2024 VS 2031

Figure 4. Hormone Drugs Features

Figure 5. Chinese Proprietary Medicine Features

Figure 6. Global Menopausal Medications Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Menopausal Medications Market Share by Application: 2024 VS 2031

Figure 8. Online Sales Case Studies

Figure 9. Offline Sales Case Studies

Figure 10. Menopausal Medications Report Years Considered

Figure 11. Global Menopausal Medications Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 12. Global Menopausal Medications Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Menopausal Medications Market Share by Region: 2024 VS 2031

Figure 14. Global Menopausal Medications Market Share by Players in 2024

Figure 15. Global Top Menopausal Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Menopausal Medications as of 2024)

Figure 16. The Top 10 and 5 Players Market Share by Menopausal Medications Revenue in 2024

Figure 17. North America Menopausal Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 18. North America Menopausal Medications Market Share by Country (2020-2031)

Figure 19. United States Menopausal Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. Canada Menopausal Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Europe Menopausal Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Menopausal Medications Market Share by Country (2020-2031)

Figure 23. Germany Menopausal Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. France Menopausal Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. U.K. Menopausal Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Italy Menopausal Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Russia Menopausal Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Nordic Countries Menopausal Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Asia-Pacific Menopausal Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Menopausal Medications Market Share by Region (2020-2031)

Figure 31. China Menopausal Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Japan Menopausal Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. South Korea Menopausal Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Southeast Asia Menopausal Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. India Menopausal Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Australia Menopausal Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Latin America Menopausal Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Menopausal Medications Market Share by Country (2020-2031)

Figure 39. Mexico Menopausal Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Brazil Menopausal Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Middle East & Africa Menopausal Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Menopausal Medications Market Share by Country (2020-2031)

Figure 43. Turkey Menopausal Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Saudi Arabia Menopausal Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. UAE Menopausal Medications Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Merck Revenue Growth Rate in Menopausal Medications Business (2020-2025)

Figure 47. Novartis Revenue Growth Rate in Menopausal Medications Business (2020-2025)

Figure 48. Novo Nordisk Revenue Growth Rate in Menopausal Medications Business (2020-2025)

Figure 49. Pfizer Revenue Growth Rate in Menopausal Medications Business (2020-2025)

Figure 50. Allergan Revenue Growth Rate in Menopausal Medications Business (2020-2025)

Figure 51. Emcure Pharmaceuticals Revenue Growth Rate in Menopausal Medications Business (2020-2025)

Figure 52. Eli Lilly And Company Revenue Growth Rate in Menopausal Medications Business (2020-2025)

Figure 53. Bayer Revenue Growth Rate in Menopausal Medications Business (2020-2025)

Figure 54. Theramex Revenue Growth Rate in Menopausal Medications Business (2020-2025)

Figure 55. AbbVie Revenue Growth Rate in Menopausal Medications Business (2020-2025)

Figure 56. Assertio(Depomed) Revenue Growth Rate in Menopausal Medications Business (2020-2025)

Figure 57. Hisamitsu Pharmaceutical Revenue Growth Rate in Menopausal Medications Business (2020-2025)

Figure 58. Roche Revenue Growth Rate in Menopausal Medications Business (2020-2025)

Figure 59. Xintian Pharmaceutical Revenue Growth Rate in Menopausal Medications Business (2020-2025)

Figure 60. Jiangxi Yaodu Zhangshu Pharmaceutical Revenue Growth Rate in Menopausal Medications Business (2020-2025)

Figure 61. Jinbao Pharmaceutical Revenue Growth Rate in Menopausal Medications Business (2020-2025)

Figure 62. Tong Ren Tang Revenue Growth Rate in Menopausal Medications Business (2020-2025)

Figure 63. Huaxi Pharmaceutical Revenue Growth Rate in Menopausal Medications Business (2020-2025)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Women s Health Care Drugs Market Research Report 2024

Global Menopause Test Kits Market Research Report 2024

Global Menopause Drugs Market Insights Forecast to 2030

Global Vitamins and Supplements for Women Market Research Report 2024

Global Menopausal Hot Flashes Medicines Market Research Report 2025

Menopausal Hot Flashes Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Menopause Hormonal Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Women s Health Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Menopause Hormonal Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Overactive Bladder Medication Market Insights Forecast to 2030

Global Menopause Wellness Market Research Report 2024

Global Osteoporosis Treatment Market Insights Forecast to 2030

Global Menopause Supplement Market Research Report 2024

Global Vasomotor Symptoms of Menopause Treatment Market Research Report 2024

Global Atherosclerosis Drugs Market Insights Forecast to 2030

Global Rheumatic Disorders Drug Market Insights Forecast to 2030

Global Drug Delivery Technology Market Research Report 2024

Global Anti aging Beauty Products Market Research Report 2024

Global Post Menopausal Osteoporosis Drug Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions